The value of TOP2A gene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D. (Q38426630)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

The value of TOP2A gene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Ann Knoop

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Susanne Møller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jan Trøst Jørgensen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Helle Knudsen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Henning T Mouridsen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Bent Ejlertsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

1 reference

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

725-734

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465341%20AND%20SRC:MED&resulttype=core&format=json

Molecular cloning and characterization of the human topoisomerase IIalpha and IIbeta genes: evidence for isoform evolution through gene duplication.

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860801995396

Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860801995396

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860801995396

Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860801995396

Current status of epirubicin (Farmorubicin) in the treatment of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860801995396

retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil:

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860801995396

Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860801995396

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860801995396

Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860801995396

HER-2 and topoisomerase II as predictors of response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860801995396